Omega Fund Management, LLC Portfolio Holdings

Omega Fund Management, LLC

  • $67.4 Million
  • Q3 2024

Omega Fund Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $67.4 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvation Bio Inc. with a value of $30.1M, Replimune Group, Inc. with a value of $27M, Ikena Oncology, Inc. with a value of $3.89M, Sana Biotechnology, Inc. with a value of $3.51M, and Immunic, Inc. with a value of $2.95M.

Examining the 13F form we can see an decrease of $9.27M in the current position value, from $76.7M to 67.4M.

Omega Fund Management, LLC is based out at Boston, MA

Below you can find more details about Omega Fund Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $67.4 Million
Healthcare: $67.4 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$58.4M
$3.89 Million 5.77% of portfolio
2,249,123
Q1 2021 New

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $67.4 Million
  • Prior Value $76.7 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Omega Fund Management, LLC Portfolio

Follow Omega Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omega Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email